The US Department of Justice (DOJ) has announced a $38.5m settlement with Aesculap Implant Systems to resolve allegations that the Pennsylvania-based medical device company sold knee replacement devices it knew would fail prematurely at a higher-than-acceptable rate, resulting in false claims to Medicare and Medicaid.
The civil settlement resolves allegations
Free Trial
Register for free to keep reading.
To continue reading this article and unlock full access to GRIP, register now. You’ll enjoy free access to all content until our subscription service launches in early 2026.
- Unlimited access to industry insights
- Stay on top of key rules and regulatory changes with our Rules Navigator
- Ad-free experience with no distractions
- Regular podcasts from trusted external experts
- Fresh compliance and regulatory content every day
